JP2024536360A5 - - Google Patents

Info

Publication number
JP2024536360A5
JP2024536360A5 JP2024520688A JP2024520688A JP2024536360A5 JP 2024536360 A5 JP2024536360 A5 JP 2024536360A5 JP 2024520688 A JP2024520688 A JP 2024520688A JP 2024520688 A JP2024520688 A JP 2024520688A JP 2024536360 A5 JP2024536360 A5 JP 2024536360A5
Authority
JP
Japan
Application number
JP2024520688A
Other languages
Japanese (ja)
Other versions
JP2024536360A (ja
JPWO2023057935A5 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2022/059527 external-priority patent/WO2023057935A1/en
Publication of JP2024536360A publication Critical patent/JP2024536360A/ja
Publication of JP2024536360A5 publication Critical patent/JP2024536360A5/ja
Publication of JPWO2023057935A5 publication Critical patent/JPWO2023057935A5/ja
Pending legal-status Critical Current

Links

JP2024520688A 2021-10-06 2022-10-06 核酸結合タンパク質を含む脂質ナノ粒子 Pending JP2024536360A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2021903192A AU2021903192A0 (en) 2021-10-06 Lipid nanoparticle comprising a RNA-binding protein
AU2021903192 2021-10-06
PCT/IB2022/059527 WO2023057935A1 (en) 2021-10-06 2022-10-06 Lipid nanoparticle comprising a nucleic acid-binding protein

Publications (3)

Publication Number Publication Date
JP2024536360A JP2024536360A (ja) 2024-10-04
JP2024536360A5 true JP2024536360A5 (https=) 2025-10-01
JPWO2023057935A5 JPWO2023057935A5 (https=) 2025-10-01

Family

ID=85803963

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024520688A Pending JP2024536360A (ja) 2021-10-06 2022-10-06 核酸結合タンパク質を含む脂質ナノ粒子

Country Status (5)

Country Link
US (1) US20240398941A1 (https=)
EP (1) EP4412592A4 (https=)
JP (1) JP2024536360A (https=)
AU (1) AU2022361756B2 (https=)
WO (1) WO2023057935A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2024250317A1 (en) * 2023-04-05 2025-11-06 Seqirus Inc. Rna delivery vehicle
CN120617495A (zh) * 2025-07-16 2025-09-12 深圳纳维疫苗科技有限公司 一种hpv重组蛋白治疗疫苗的制备方法与应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6210707B1 (en) * 1996-11-12 2001-04-03 The Regents Of The University Of California Methods of forming protein-linked lipidic microparticles, and compositions thereof
JP2006506101A (ja) * 2002-11-13 2006-02-23 ルトガーズ、ザ ステイト ユニバーシティ インフルエンザウイルス非構造タンパク質1の阻害剤を設計する方法
WO2010087994A2 (en) * 2009-01-30 2010-08-05 Whitehead Institute For Biomedical Research Methods for ligation and uses thereof
ES2762873T3 (es) * 2012-03-29 2020-05-26 Translate Bio Inc Lípidos catiónicos ionizables
EP2875128B8 (en) * 2012-07-19 2020-06-24 Oxford Nanopore Technologies Limited Modified helicases
US9809632B2 (en) * 2013-10-23 2017-11-07 University Of Washington Through Its Center For Commercialization Universal protein tag for double stranded nucleic acid delivery
SG10201912038TA (en) * 2014-04-23 2020-02-27 Modernatx Inc Nucleic acid vaccines

Similar Documents

Publication Publication Date Title
BR102022025291A2 (https=)
BR102023014872A2 (https=)
BR102023012440A2 (https=)
BR102023010976A2 (https=)
BR102023009641A2 (https=)
BR102023008688A2 (https=)
BR102023007252A2 (https=)
BR102023005164A2 (https=)
BR102023001877A2 (https=)
BR102023000289A2 (https=)
BR102022026909A2 (https=)
BR102022023461A2 (https=)
BR202022009269U2 (https=)
BR202022005961U2 (https=)
BR202022001779U2 (https=)
BR202022000931U2 (https=)
BY13149U (https=)
BY13159U (https=)
BY13140U (https=)
BY13141U (https=)
BY13142U (https=)
BY13143U (https=)
BY13135U (https=)
BY13145U (https=)
BY13169U (https=)